- Home
- EVOK vs ISPC Comparison
EVOK vs ISPC Comparison
Compare EVOK & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- ISPC
- Stock Information
- Founded
- EVOK 2007
- ISPC 2009
- Country
- EVOK United States
- ISPC United States
- Employees
- EVOK N/A
- ISPC N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- ISPC Precision Instruments
- Sector
- EVOK Health Care
- ISPC Health Care
- Exchange
- EVOK Nasdaq
- ISPC Nasdaq
- Market Cap
- EVOK 7.6M
- ISPC 6.9M
- IPO Year
- EVOK 2013
- ISPC 2021
- Fundamental
- Price
- EVOK $5.15
- ISPC $0.78
- Analyst Decision
- EVOK
- ISPC
- Analyst Count
- EVOK 0
- ISPC 0
- Target Price
- EVOK N/A
- ISPC N/A
- AVG Volume (30 Days)
- EVOK 26.0K
- ISPC 504.9K
- Earning Date
- EVOK 11-07-2025
- ISPC 11-14-2025
- Dividend Yield
- EVOK N/A
- ISPC N/A
- EPS Growth
- EVOK N/A
- ISPC N/A
- EPS
- EVOK N/A
- ISPC N/A
- Revenue
- EVOK $12,794,859.00
- ISPC $5,908,088.00
- Revenue This Year
- EVOK $57.38
- ISPC $35.93
- Revenue Next Year
- EVOK $59.57
- ISPC N/A
- P/E Ratio
- EVOK N/A
- ISPC N/A
- Revenue Growth
- EVOK 70.02
- ISPC N/A
- 52 Week Low
- EVOK $1.94
- ISPC $0.64
- 52 Week High
- EVOK $9.88
- ISPC $5.48
- Technical
- Relative Strength Index (RSI)
- EVOK 57.04
- ISPC 40.77
- Support Level
- EVOK $4.53
- ISPC $0.75
- Resistance Level
- EVOK $5.19
- ISPC $0.86
- Average True Range (ATR)
- EVOK 0.28
- ISPC 0.07
- MACD
- EVOK 0.07
- ISPC 0.01
- Stochastic Oscillator
- EVOK 91.26
- ISPC 31.20
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.